These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6740566)

  • 1. Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarins.
    Andersson G; Fagrell B; Holmgren K; Johnsson H; Ljungberg B; Wilhelmsson S
    Thromb Res; 1984 May; 34(4):333-40. PubMed ID: 6740566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antithrombin III deficiency as a risk factor in postoperative thrombosis].
    Van Betsbrugge M
    Acta Chir Belg; 1985; 85(5):299-302. PubMed ID: 4082851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antithrombin III levels in patients with acute thromboembolism during treatment with heparin].
    Barja P; Araya MV; Hassi M
    Rev Med Chil; 1986 Dec; 114(12):1160-3. PubMed ID: 3602697
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of continuous low-dose intravenous heparin administered during operation on postoperative measurements of antithrombin III and antifactor Xa.
    Jennings SA; Heather BP; Greenhalgh RM
    Surgery; 1984 Sep; 96(3):550-5. PubMed ID: 6474360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of operation and subcutaneous heparin on plasma levels of antithrombin-III.
    Harbourne T; Nicolaides AN
    Thromb Res; 1986 Sep; 43(6):657-62. PubMed ID: 3764810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombin-antithrombin III complexes as a measure of effective heparin treatment?].
    Meyer D; Tsakiris DA; Marbet GA
    Schweiz Med Wochenschr; 1989 Sep; 119(39):1352-4. PubMed ID: 2678451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
    Breddin HK; Kadziola Z; Scully M; Nakov R; Misselwitz F; Kakkar VV
    Thromb Haemost; 2003 Feb; 89(2):272-7. PubMed ID: 12574806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Deep vein thrombosis in pregnancy: current concept of diagnosis and treatment (author's transl)].
    Weil A; Freund R
    Schweiz Rundsch Med Prax; 1978 Jun; 67(26):966-72. PubMed ID: 674076
    [No Abstract]   [Full Text] [Related]  

  • 10. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma antithrombin (heparin cofactor activity) during intravenous heparin therapy: observations in 198 patients with deep venous thrombosis.
    Holm HA; Kalvenes S; Abildgaard U
    Scand J Haematol; 1985 Nov; 35(5):564-9. PubMed ID: 4089534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.
    Levine M; Gent M; Hirsh J; Leclerc J; Anderson D; Weitz J; Ginsberg J; Turpie AG; Demers C; Kovacs M
    N Engl J Med; 1996 Mar; 334(11):677-81. PubMed ID: 8594425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thrombosis after total hip arthroplasty. Antithrombin III and low-dose heparin compared with dextran 40.
    Francis CW; Pellegrini VD; Marder VJ; Harris CM; Totterman S; Gabriel KR; Baughman DJ; Roemer S; Burke J; Goodman TL
    J Bone Joint Surg Am; 1989 Mar; 71(3):327-35. PubMed ID: 2466846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in acute deep vein thrombosis: effects of heparin treatment.
    Estivals M; Pelzer H; Sie P; Pichon J; Boccalon H; Boneu B
    Br J Haematol; 1991 Jul; 78(3):421-4. PubMed ID: 1873225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antithrombin III in 86 patients with venous thrombosis (author's transl)].
    Juillet Y; Aiach M; Fiessinger JN; Leclerc M; Housset E
    Sem Hop; 1978 Nov 8-15; 54(37-40):1126-9. PubMed ID: 217091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.
    Kearon C; Harrison L; Crowther M; Ginsberg JS
    Thromb Res; 2000 Mar; 97(6):395-403. PubMed ID: 10704648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III in patients treated with subcutaneous or intravenous heparin.
    Conard J; Lecompte T; Horellou MH; Cazenave B; Samama M
    Thromb Res; 1981 May; 22(4):507-11. PubMed ID: 7292454
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
    Monreal M; Lafoz E; Olive A; del Rio L; Vedia C
    Thromb Haemost; 1994 Jan; 71(1):7-11. PubMed ID: 8165649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against venous thrombosis in an antithrombin-III deficient patient suffering from episodes of arterial thrombosis requiring major surgery. Effects of oral stanozolol in combination with subcutaneous heparin and intravenous AT-III.
    Jespersen J; Gram J; Kluft C; Astrup T
    Am J Clin Pathol; 1985 Jun; 83(6):768-71. PubMed ID: 4003344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.